Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access ...

Relief is coming for more than 5 million Medicare beneficiaries who rely on expensive prescription medications.

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

The Trump administration announced Friday it will not move forward with plans to cover popular weight-loss drugs under ...

Typically, Medicare Part D will cover Ozempic to help manage blood sugar levels in adults with type 2 diabetes. Medicare does not cover Ozempic to treat prediabetes, which is an off-label use.

Democrat senators are begging Health and Human Services Secretary (HHS) Robert F. Kennedy Jr. to keep a proposed Biden-era rule pertaining to obesity drugs. In November, the […] ...

Medicare Advantage updates while halting proposed anti-obesity drug coverage, impacting millions of potential beneficiaries.

As discussions unfold, Kennedy seeks to balance drug accessibility with concerns about the long-term costs of providing GLP-1 ...

The Trump administration has decided against implementing a proposal for Medicare and Medicaid to cover weight loss drugs, the Centers for Medicare and Medicaid Services said in a filing published ...

In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...